≡

Recombinant V-Set Domain Containing T-Cell Activation Inhibitor 1 (VTCN1)

B7-H4; B7H4; B7S1; B7X; B7h.5; VCTN1; T-cell costimulatory molecule B7x; Immune costimulatory protein B7-H4

  • Product No.RPK032Hu03
  • Organism SpeciesHomo sapiens (Human) Same name, Different species.
  • SourceProkaryotic expression
  • HostE.coli
  • Endotoxin Level<1.0EU per 1µg (determined by the LAL method)
  • Subcellular LocationSecreted
  • Predicted Molecular Mass29.5kDa
  • Accurate Molecular Mass32kDa(Analysis of differences refer to the manual)
  • Residues & TagsLeu25~Ser259 with N-terminal His Tag
  • Buffer FormulationPBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
  • Traits Freeze-dried powder
  • Purity> 90%
  • Isoelectric Point4.8
  • Applications Positive Control; Immunogen; SDS-PAGE; WB.
    If bio-activity of the protein is needed, please check active protein.
  • DownloadInstruction Manual
  • UOM 10µg50µg 200µg 1mg 5mg
  • FOB US$ 192  US$ 480  US$ 960  US$ 2880  US$ 7200 
    For more details, please contact local distributors!

SEQUENCE

USAGE

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

STORAGE

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
International Journal of Clinical Oncology Expression of costimulatory molecules B7-H1, B7-H4 and Foxp3+ Tregs in gastric cancer and its clinical significance Pubmed:24804867
Iranian Journal of Immunology Increased Serum Levels of Soluble B7-H4 in Patients with Systemic Lupus Erythematosus. Pubmed: 30864554
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPK032Hu02 Recombinant V-Set Domain Containing T-Cell Activation Inhibitor 1 (VTCN1) Positive Control; Immunogen; SDS-PAGE; WB.
RPK032Hu03 Recombinant V-Set Domain Containing T-Cell Activation Inhibitor 1 (VTCN1) Positive Control; Immunogen; SDS-PAGE; WB.
RPK032Hu01 Recombinant V-Set Domain Containing T-Cell Activation Inhibitor 1 (VTCN1) Positive Control; Immunogen; SDS-PAGE; WB.
PAK032Hu01 Polyclonal Antibody to V-Set Domain Containing T-Cell Activation Inhibitor 1 (VTCN1) WB; IHC; ICC; IP.
PAK032Hu03 Polyclonal Antibody to V-Set Domain Containing T-Cell Activation Inhibitor 1 (VTCN1) WB; IHC; ICC; IP.
PAK032Hu02 Polyclonal Antibody to V-Set Domain Containing T-Cell Activation Inhibitor 1 (VTCN1) WB; IHC; ICC; IP.
LAK032Hu71 Biotin-Linked Polyclonal Antibody to V-Set Domain Containing T-Cell Activation Inhibitor 1 (VTCN1) WB; IHC; ICC.
LAK032Hu81 FITC-Linked Polyclonal Antibody to V-Set Domain Containing T-Cell Activation Inhibitor 1 (VTCN1) WB; IHC; ICC; IF.
MAK032Hu21 Monoclonal Antibody to V-Set Domain Containing T-Cell Activation Inhibitor 1 (VTCN1) WB; IHC; ICC; IP.
SEK032Hu ELISA Kit for V-Set Domain Containing T-Cell Activation Inhibitor 1 (VTCN1) Enzyme-linked immunosorbent assay for Antigen Detection.
LMK032Hu Multiplex Assay Kit for V-Set Domain Containing T-Cell Activation Inhibitor 1 (VTCN1) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.